Sterile Manufacturing & WHO-GMP for Injectables and Eye Drops

When a product has to enter the bloodstream or sit on the surface of an eye, there is no margin for a stray microbe. That is the whole reason sterile pharmaceutical manufacturing exists as a category of its own — and it is why an injection, an IV infusion or an eye drop simply cannot be made the way a tablet is. For a buyer sourcing these forms, the supplier’s claim of “sterile” hides a lot of detail that decides whether your stock passes audit and reaches patients safely. This guide unpacks what the term actually covers, in plain commercial language, so you know what to ask for and what to verify.

Key takeaways (TL;DR)

Sterile means the finished product is free of viable micro-organisms — mandatory for anything injected or applied to the eye.
It is achieved one of two ways: terminal sterilisation (sterilised in the final container) or aseptic processing (built sterile, step by step). Each suits different products.
Cleanrooms are graded A to D; the riskier the step, the cleaner the air it happens in.
WHO-GMP and India’s revised Schedule M set the rules for facilities, validation and batch records that make “sterile” auditable rather than just a label.
Before you buy injectables, infusions or eye drops, verify the certificate scope, the sterilisation method and the QC evidence — not just the price.

What “sterile” actually means for a buyer

Sterility is not a degree of cleanliness — it is an absolute. A sterile product carries no living micro-organisms capable of multiplying, full stop. That standard applies to a narrow but critical set of dosage forms: anything that bypasses the body’s natural barriers. Injections and IV infusions go straight into tissue or the bloodstream, and ophthalmic preparations like eye drops land on a surface with almost no defence against contamination. For these, sterility is a legal and clinical requirement, not a quality upgrade. Compare that with a tablet or a syrup, where the body’s gut and skin offer a buffer, and the difference in how seriously the production environment has to be controlled becomes obvious.

Two routes to sterile: terminal vs aseptic

There are essentially two ways to arrive at a sterile product, and which one your supplier uses tells you a lot about the product and the facility behind it.

Terminal sterilisation

Here the product is filled and sealed first, then the whole sealed unit is sterilised — most commonly with heat in an autoclave. Because the final container itself is treated, the chance of a surviving micro-organism is extremely low and easy to prove statistically. Large-volume IV infusions and many water-based injectables are made this way. The catch: the formulation has to survive the heat, so heat-sensitive molecules cannot use this route.

Aseptic processing

When a product cannot be heated — many biologics, certain antibiotics, delicate eye-drop formulations — it must be assembled sterile from the start. Every component is sterilised separately, then filled and sealed inside an ultra-clean environment without a final sterilisation step. There is no rescue at the end, so the entire line, the air, the operators and the validation behind them carry the burden. Aseptic processing is harder, costlier and demands tighter control, which is exactly why proven aseptic capability is a genuine differentiator in a supplier.

Aspect	Terminal sterilisation	Aseptic processing
When it’s used	Heat-stable products	Heat-sensitive products
Typical forms	IV infusions, many injectables	Sensitive injectables, some eye drops
Sterilised	In the final sealed container	Each component, before filling
Margin for error	Higher — final step catches risk	Lower — no final safety net
Preferred where possible	Yes, when the molecule allows	Only when heat isn’t an option

Cleanroom grades, in plain language

The “controlled environment” behind sterile manufacturing isn’t a single room — it is a set of zones, each with a defined limit on how many particles and microbes the air may carry. Under GMP these are labelled Grade A through Grade D, and the principle is simple: the closer a step gets to the open, unsealed product, the cleaner the air around it has to be.

Grade A — the critical zone where open product is filled and sealed. The cleanest air in the plant, with constant laminar airflow.
Grade B — the background environment surrounding a Grade A aseptic-filling zone.
Grade C — for less critical preparation stages, such as solution mixing before sterilisation.
Grade D — cleaner-than-normal support areas, for early handling and component prep.

For a buyer, the takeaway is that a facility making eye drops or injectables should be able to describe its grade structure and gowning, air-monitoring and pressure-cascade controls. A maker that talks fluently about its Grade A/B fill area is signalling real sterile capability; vagueness here is a red flag.

What WHO-GMP and Schedule M actually assure

A “sterile” label means little without a system that proves it batch after batch. That system is what good manufacturing practice provides. WHO-GMP is an internationally recognised standard, and in India the revised Schedule M of the Drugs and Cosmetics Rules sets the binding local requirements — with dedicated, stricter expectations for sterile products. Together they convert a sterility claim into something an auditor, a distributor or an institutional buyer can rely on, because they govern the things that fail quietly when they’re skipped:

Facility design — properly graded cleanrooms, air handling and segregation of sterile areas.
Validation — documented proof that sterilisation cycles and aseptic fills consistently work, including media fills that simulate production.
Environmental monitoring — ongoing checks on air, surfaces and water quality.
Batch records and QC — sterility testing, traceable documentation and release controls for every batch.
Trained personnel — gowning discipline and competence, since people are the biggest contamination risk in aseptic work.

When a supplier holds WHO-GMP and works to Schedule M, you are not taking sterility on trust — you are relying on an audited quality system designed to keep it consistent.

What to verify before you source sterile products

If you are adding injectables, infusions or ophthalmics to your range, a few targeted checks separate a dependable sterile partner from a risky one:

Certificate scope — confirm the WHO-GMP and ISO certificates actually cover the sterile dosage form you want, not just oral products.
Sterilisation method — ask whether the product is terminally sterilised or aseptically filled, and why that route fits it.
Cleanroom evidence — expect a clear answer on cleanroom grades and environmental monitoring.
QC documentation — sterility test results, stability data and batch records you can review.
Form breadth — a maker who already runs injections, IV infusions and eye drops can scale your range without you re-vetting a new supplier each time.

Biozia Lifesciences is built around exactly this kind of sterile strength. WHO-GMP and ISO certified and based in Yamunanagar, Haryana, it manufactures injections, IV infusions and eye drops alongside its wider range of 250+ formulations across nine dosage forms — from a Linezolid IV injection and a Paracetamol 1000mg/100ml infusion to Olopatadine and Moxifloxacin-with-Loteprednol eye drops. With chairman Anil Kumar Goel’s 40+ years in pharma behind it and pan-India supply, it offers the sterile and ophthalmic capability many contract makers simply can’t.

Sourcing injectables, infusions or eye drops? Request a manufacturing quote from Biozia Lifesciences →

Frequently asked questions

Why do injectables and eye drops have to be sterile when tablets don’t?

Injectables and infusions enter tissue or the bloodstream directly, and eye drops land on a surface with very little natural defence, so any micro-organism present can cause serious harm. Tablets and syrups pass through the gut, which offers a degree of protection, so they are made to high quality standards but not full sterility.

What is the difference between terminal sterilisation and aseptic processing?

In terminal sterilisation the product is filled and sealed first, then the whole container is sterilised, usually with heat. In aseptic processing the product can’t be heated, so every component is sterilised separately and assembled in an ultra-clean environment with no final sterilisation step. Aseptic work demands tighter control because there is no safety net at the end.

What do cleanroom grades A to D mean?

They define how clean the air must be at each stage. Grade A is the critical zone where open product is filled, with the cleanest air; Grade B is its surrounding background; Grade C and D cover less critical preparation and support steps. The closer a step is to exposed product, the higher the grade required.

What does WHO-GMP assure for a sterile product?

It confirms the product is made under an audited quality system covering cleanroom design, validated sterilisation, environmental monitoring, batch records and trained staff. It turns a sterility claim into something a distributor or institutional buyer can rely on, batch after batch.

How do I check a supplier can really make sterile products?

Confirm the certificate scope covers your specific dosage form, ask which sterilisation method is used and why, request details of cleanroom grades and environmental monitoring, and review QC evidence such as sterility tests and batch records. A maker already running injectables, infusions and eye drops is a strong signal.

Author: Biozia Lifesciences Editorial Team — insights drawn from Biozia Lifesciences’ WHO-GMP & ISO-certified manufacturing and PCD franchise operations in India, led by 40+ years of industry experience. This article is general business information and not medical or legal advice.